SEC Comment Letter 0000000000-25-000552 to Traws Pharma, Inc. (TRAW) (CIK 0001130598) (TRAW)
Traws Pharma, Inc. (TRAW) (CIK 0001130598)
Date: Jan. 17, 2025 · CIK: 0001130598 · Accession: 0000000000-25-000552
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284285
Letter
January 17, 2025 Werner Cautreels Chief Executive Officer Traws Pharma, Inc. 12 Penns Trail Newtown, PA 18940 Re:Traws Pharma, Inc. Registration Statement on Form S-3 Filed January 15, 2025 File No. 333-284285 Dear Werner Cautreels: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Christopher L. Tinen, Esq.
Show Raw Text
January 17, 2025
Werner Cautreels
Chief Executive Officer
Traws Pharma, Inc.
12 Penns Trail
Newtown, PA 18940
Re:Traws Pharma, Inc.
Registration Statement on Form S-3
Filed January 15, 2025
File No. 333-284285
Dear Werner Cautreels:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Christopher L. Tinen, Esq.